MLchartDataset catalogue

Pyrazoloacridine

Term · Oncology and biomedicine · MLC-T-ONC-007110

  1. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called acridines.

  2. A 9-methoxy acridine compound containing a reducible 5-nitro substituent. Pyrazoloacridine appears to intercalate into DNA and inhibit RNA synthesis, DNA synthesis, and the activities of topoisomerases I and II, thereby causing cytotoxicity.

Table 1. Record
IdentifierMLC-T-ONC-007110
FieldOncology and biomedicine
AbbreviationPZA
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-007110",
  "term": "Pyrazoloacridine",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called acridines.",
    "A 9-methoxy acridine compound containing a reducible 5-nitro substituent. Pyrazoloacridine appears to intercalate into DNA and inhibit RNA synthesis, DNA synthesis, and the activities of topoisomerases I and II, thereby causing cytotoxicity."
  ],
  "abbreviation": "PZA",
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/pyrazoloacridine/"
}

Record 13,903 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.